GlaxoSmithKline's Shingrix Approved in the U.S. for Prevention of Shingles in Adults Aged 50 and … Post author:Sam Post published:October 22, 2017 Post category:BioPharma Shingrix is a non-live, recombinant subunit vaccine given intramuscularly in two doses. Source: BioSpace You Might Also Like Why This Heart Drug Could Be a $5B Blockbuster for Novartis January 23, 2018 Booming Rho to Go on 40-Person+ Hiring Binge September 18, 2017 Ag Biotech Company Announces $24MM C Round Financing July 9, 2017
